Literature DB >> 18039463

Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A.

Shinya Mimasu1, Toru Sengoku, Seketsu Fukuzawa, Takashi Umehara, Shigeyuki Yokoyama.   

Abstract

Transcriptional activity and chromatin structure accessibility are correlated with the methylation of specific histone residues. Lysine-specific demethylase 1 (LSD1) is the first discovered histone demethylase, which demethylates Lys4 or Lys9 of histone H3, using FAD. Among the known monoamine oxidase inhibitors, tranylcypromine (Parnate) showed the most potent inhibitory effect on LSD1. Recently, the crystal structure of LSD1 and tranylcypromine was solved at 2.75 A, revealing a five-membered ring fused to the flavin of LSD1. In this study, we refined the crystal structure of the LSD1-tranylcypromine complex to 2.25 A. The five-membered ring model did not fit completely with the electron density, giving R(work)/R(free) values of 0.226/0.254. On the other hand, the N(5) adduct gave the lowest R(work)/R(free) values of 0.218/0.248, among the tested models. These results imply that the LSD1-tranylcypromine complex is not completely composed of the five-membered adduct, but partially contains an intermediate, such as the N(5) adduct.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18039463     DOI: 10.1016/j.bbrc.2007.11.066

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

Review 1.  Structural insights into histone lysine demethylation.

Authors:  Haifeng Hou; Hongtao Yu
Journal:  Curr Opin Struct Biol       Date:  2010-10-21       Impact factor: 6.809

2.  Lysine-specific histone demethylase 1 inhibitors control breast cancer proliferation in ERα-dependent and -independent manners.

Authors:  Julie A Pollock; Michelle D Larrea; Jeff S Jasper; Donald P McDonnell; Dewey G McCafferty
Journal:  ACS Chem Biol       Date:  2012-05-10       Impact factor: 5.100

3.  Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity.

Authors:  Martin L Schmitt; Alexander-Thomas Hauser; Luca Carlino; Martin Pippel; Johannes Schulz-Fincke; Eric Metzger; Dominica Willmann; Teresa Yiu; Michelle Barton; Roland Schüle; Wolfgang Sippl; Manfred Jung
Journal:  J Med Chem       Date:  2013-09-05       Impact factor: 7.446

Review 4.  Chemical probes for histone-modifying enzymes.

Authors:  Philip A Cole
Journal:  Nat Chem Biol       Date:  2008-10       Impact factor: 15.040

5.  CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression.

Authors:  Hung-Chih Hsu; Yi-Shiuan Liu; Kai-Chi Tseng; Tsai-Sheng Yang; Chien-Yuh Yeh; Jeng-Fu You; Hsin-Yuan Hung; Shu-Jen Chen; Hua-Chien Chen
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-25       Impact factor: 4.553

Review 6.  KDM1 class flavin-dependent protein lysine demethylases.

Authors:  Jonathan M Burg; Jennifer E Link; Brittany S Morgan; Frederick J Heller; Amanda E Hargrove; Dewey G McCafferty
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

Review 7.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

Review 8.  The role of histone demethylases in cancer therapy.

Authors:  Inga Hoffmann; Martin Roatsch; Martin L Schmitt; Luca Carlino; Martin Pippel; Wolfgang Sippl; Manfred Jung
Journal:  Mol Oncol       Date:  2012-08-07       Impact factor: 6.603

9.  Targeting Histone Demethylases: A New Avenue for the Fight against Cancer.

Authors:  Dante Rotili; Antonello Mai
Journal:  Genes Cancer       Date:  2011-06

10.  Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2.

Authors:  Wenlin Li; HongYan Zhou; Ramzey Abujarour; Saiyong Zhu; Jin Young Joo; Tongxiang Lin; Ergeng Hao; Hans R Schöler; Alberto Hayek; Sheng Ding
Journal:  Stem Cells       Date:  2009-12       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.